Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ma, Lei ^a   Jia, Ji ^a   Niu, Wen ^b   Jiang, Tao ^a   Zhai, Qian ^a   Yang, Lei ^a   Bai, Fuhai ^a   Wang, Qiang ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR;

ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; METABOLISM; MITOCHONDRION; MOUSE; NERVE CELL; UPREGULATION;

ANIMALS; ARACHIDONIC ACIDS; CELLS, CULTURED; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NEURONS; RECEPTOR, CANNABINOID, CB1; UP-REGULATION;

EID: 84938246159     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12440     Document Type: Article

References (46)

1. Laver, S., Farrow, C., Turner, D. & Nolan, J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 30, 2126-2128 (2004).
2. Nichol, G. et al. Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association. Circulation 121, 709-729 (2010).
3. Roine, R. O., Kajaste, S. & Kaste, M. Neuropsychological sequelae of cardiac arrest. JAMA 269, 237-242 (1993).
4. MacAskill, A. F. & Kittler, J. T. Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20, 102-112 (2010).
5. Mattson, M. P., Gleichmann, M. & Cheng, A. Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748-766 (2008).
6. Galindo, M. F., Ikuta, I., Zhu, X., Casadesus, G. & Jordán, J. Mitochondrial biology in Alzheimer's disease pathogenesis. J Neurochem 114, 933-945 (2010).
7. Vosler, P. S., Graham, S. H., Wechsler, L. R. & Chen, J. Mitochondrial targets for stroke: focusing basic science research toward development of clinically translatable therapeutics. Stroke 40, 3149-3155 (2009).
8. Anne, Stetler. R., Leak, R. K., Gao, Y. & Chen, J. The dynamics of the mitochondrial organelle as a potential therapeutic target. J Cereb Blood Flow Metab 33, 22-32 (2013).
9. Perez-Pinzon, M. A., Stetler, R. A. & Fiskum, G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab 32, 1362-1376 (2012).
10. Marsicano, G. et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84-88 (2003).
11. Iversen, L. Cannabis and the brain. Brain 126, 1252-1270 (2003).
12. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89, 309-380 (2009).
13. Gilbert, G. L., Kim, H. J., Waataja, J. J. & Thayer, S. A. Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res 1128, 61-69 (2007).
14. Bartova, A. & Birmingham, M. K. Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity. J Biol Chem 251, 5002-5006 (1976).
15. Tedesco, L. et al. Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes 59, 2826-2836 (2010).
16. Aquila, S. et al. Human sperm anatomy: ultrastructural localization of the cannabinoid 1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. Anat Rec (Hoboken) 293, 298-309 (2010).
17. Sim-Selley, L. J. & Martin, B. R. Effect of chronic administration of R-(+ )-[2, 3-Dihydro-5-methyl-3-[(morpholinyl)methyl] pyrrolo[1, 2, 3-de]-1, 4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55, 212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 303, 36-44 (2002).
18. Tomiyama, K. & Funada, M. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death. Toxicol Appl Pharmacol 274, 17-23 (2014).
19. Bénard, G. et al. Mitochondrial CBi receptors regulate neuronal energy metabolism. Nat Neurosci 15, 558-564 (2012).
20. Proto, M. C. et al. Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. J Cell Physiol 227, 250-258 (2012).
21. Laprairie, R. B., Kelly, M. E. & Denovan-Wright, E. M. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease. Neuropharmacology 72, 47-57 (2013).
22. Ye, R. D. et al. Sevoflurane preconditioning improves mitochondrial function and long-term neurologic sequelae after transient cerebral ischemia: role of mitochondrial permeability transition. Crit Care Med 40, 2685-2693 (2012).
23. Sun, J. et al. Inhibition of mitochondrial permeability transition pore opening contributes to the neuroprotective effects of ischemic postconditioning in rats. Brain Res 1436, 101-110 (2012).
24. Nagayama, T. et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19, 2987-2995 (1999).
25. Leker, R. R., Gai, N., Mechoulam, R. & Ovadia, H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 34, 2000-2006 (2003).
26. Hillard, C. J. et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289, 1427-1433 (1999).
27. Pacher, P. & Haskó, G. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 153, 252-262 (2008).
28. Suzuki, N. et al. Contribution of hypothermia and CB1 receptor activation to protective effects of TAK-937, a cannabinoid receptor agonist, in rat transient MCAO model. PLoS One 7, e40889 (2012).
29. Heimann, A. S. et al. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci USA 104, 20588-20593 (2007).
30. Fujii, M. et al. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28, 1805-1810 (1997).
31. Yang, G. et al. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: selective neuronal death in the murine transient forebrain ischemia. Brain Res 752, 209-218 (1997).
32. Murakami, Y. et al. Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J Neurochem 93, 1616-1622 (2005).
33. Cho, J. Y., Kim, I. S., Jang, Y. H., Kim, A. R. & Lee, S. R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci Lett 404, 330-335 (2006).
34. Huang, Y. & McNamara, J. O. Ischemic stroke: "acidotoxicity" is a perpetrator. Cell 118, 665-666 (2004).
35. Schon, E. A. & Przedborski, S. Mitochondria: the next (neurode) generation. Neuron 70, 1033-1053 (2011).
36. Lipton, P. Ischemic cell death in brain neurons. Physiol Rev 79, 1431-1568 (1999).
37. Sims, N. R. & Muyderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 1802, 80-91 (2010).
38. Sanderson, T. H., Reynolds, C. A., Kumar, R., Przyklenk, K. & Hüttemann, M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 47, 9-23 (2013).
39. Racay, P. et al. Mitochondrial calcium transport and mitochondrial dysfunction after global brain ischemia in rat hippocampus. Neurochem Res 34, 1469-1478 (2009).
40. Iijima, T. Mitochondrial membrane potential and ischemic neuronal death. Neurosci Res 55, 234-243 (2006).
41. Li, J. et al. Reperfusion promotes mitochondrial dysfunction following focal cerebral ischemia in rats. PLoS One 7, e46498 (2012).
42. Elimadi, A., Jullien, V., Tillement, J. P. & Morin, D. S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties. Eur J Pharmacol 468, 93-101 (2003).
43. Wu, L. et al. The neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mitochondrial permeability transition pore. Neurosci Lett 402, 184-189 (2006).
44. Rozenfeld, R. & Devi, L. A. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 22, 2311-2322 (2008).
45. Dodd, G. T., Mancini, G., Lutz, B. & Luckman, S. M. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice. J Neurosci 30, 7369-7376 (2010).
46. Wang, Q. et al. Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1. Stroke 42, 389-396 (2011).